Brain Scientific (OTCQB: BRSF) vice president of marketing Stuart Bernstein has authored a DotMed Healthcare Business News article titled “COVID’s influence on neurology drives need for disposable technologies.” In the article, Bernstein notes both time management and infection control as key factors in the growing need for disposable technologies. The article states that headsets with pre-gelled and fixed electrodes could reduce the time-consuming electrode placement process. In addition, the article explains that commercially available EEG headsets that pair with encephalographs and amplifiers of EEG signals can deliver results in an average of 20 minutes. These time-saving measures mean that doctors could receive results faster and take more informed actions. Bernstein also points out that infection control is essential, with disposable EEG headsets allowing healthcare professions to administer tests and receive results without losing time for cleaning equipment or risking transmission through shared devices. Brain Scientific is a neurology-focused medical device and software company that is providing next-gen solutions to the neurology market. “Disposable EEG headsets are an efficient and cost-effective solution that should be integrated into the standard-of-care across healthcare facilities to enable faster and more reliable identification and analysis of neurological conditions in emergent patients, during the pandemic and moving forward,” stated Brain Scientific marketing VP Stuart Bernstein in the article.
To view the full article, visit https://ibn.fm/o67K4
About Brain Scientific
Brain Scientific is a commercial-stage, health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. For more information about this company, please visit www.BrainScientific.com.
NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork